Our goal is to release and recommend the vaccine so that it can coincide as much as possible with the peak of the season," Dr. Nirav Shah, CDC's principal deputy director, said in an interview.
Two more lab groups—one from Sweden's Karolinska Institute and the other from Harvard University—have reported results of antibody neutralization lab experiments, which suggest vaccination or previous infection offer some protection against the highly mutated BA.2.86 SARS-CoV-2 variant.
" We find that federal fiscal assistance dollars had a modest if any impact on the pace of vaccine rollouts, may have improved the equitability of vaccine administration, and had a substantial impact on the volume of tests administered...."